Artificial Heart | Medical XPRT
Articles & Whitepapers
-
SmartFreezer®: Meeting the Medical Device Directive for Safe Sample Management
Medical devices are an essential component of healthcare, and they have significantly improved the quality of life for many patients worldwide. These devices may be categorised by their intended use and range from simple non-invasive items to fully implantable devices. The Medical Device Directive 93/42/EEC (MDD) is a regulation that sets out the essential requirements that medical devices must ...
-
Titanium but not just titanium
Titanium and its alloys have many advantages as surgical implant materials, such as low density, high strength, good toughness, good biocompatibility, non-toxicity, low elastic modulus, good ...
News
-
CARMAT anticipates implants of its Aeson artificial heart to resume in October 2022
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical needby providing a therapeuticalternative to people suffering from end-stage biventricular heart ...
T,C&A Lab Declares Capability of Biomedical Materials Testing
CARMAT announces the completion of its investigations on previously identified quality issues
CARMAT voluntarily suspends Aeson implantations on a temporary basis
CARMAT announces the first implant of its Aeson total artificial heart in The Netherlands
Equipment & Solutions
-
Showcase
Temporary Total Artificial Heart
The SynCardia 70cc temporary Total Artificial Heart (TAH) is the world’s first and only commercially approved total heart replacement. With more than 1,700 implants worldwide, the 70cc TAH accounts for more than 600 patient-years of support.